Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-24 @ 7:42 PM
NCT ID:
NCT06900803
Eligibility Criteria:
Inclusion Criteria:
* adults aged 20 or older
* a diagnosis of HFrEF, which is defined by a left ventricular ejection fraction of 40% or less
* currently receiving sacubitril/valsartan at the time of recruitment
* receiving care at the cardiology department or cardiology ward at National Taiwan University Hospital
* referral from the clinicians at National Taiwan University Hospital
Exclusion Criteria:
* unable or unwilling to provide informed consent, adhere to study protocols, or complete required questionnaires in person during three scheduled visits (i.e., 3, 6, 12 months after the baseline measurement)
* having received care at the pharmacist-led HF clinic at National Taiwan University Hospital
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT06900803
Study Brief:
Protocol Section:
NCT06900803